help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1145
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/9/5463    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paperna, T.
Right arrow Articles by Hochberg, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paperna, T.
Right arrow Articles by Hochberg, Z.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 9 5463-5465
Copyright © 2005 by The Endocrine Society


BRIEF REPORT

Mutations in CYP11B1 and Congenital Adrenal Hyperplasia in Moroccan Jews

Tamar Paperna, Ruth Gershoni-Baruch, Kader Badarneh, Leah Kasinetz and Ze’ev Hochberg

Genetics Institute (T.P., R.G.-B., K.B., L.K.) and Division of Endocrinology, Meyer Children’s Hospital, Rambam Medical Center (Z.H.), Technion–Israel Institute of Technology (T.P., R.G.-B., Z.H.), Haifa 31096, Israel

Address all correspondence and requests for reprints to: Dr. Ze’ev Hochberg, Meyer Children’s Hospital, P.O.B. 9602, Haifa 31096, Israel. E-mail: z_hochberg{at}rambam.health.gov.il.

Context: In Jews of Moroccan descent (MJ), the prevalence of steroid 11ß-hydroxylase deficiency (11-OHD) is relatively high, with a carrier rate estimated as approximately one in 40. A single mutation in the CYP11B1 gene (encoding 11ß-hydroxylase), R448H, was suggested to account for the disease alleles in this population.

Study Subjects: We screened 236 healthy MJ for R448H.

Results: Only two of the subjects screened were found to be carriers, suggesting that the R448H allele frequency is lower than was assumed previously. An R448H/R448C compound heterozygote patient, diagnosed with 11-OHD, was identified. However, a subsequent screen of MJ subjects for R448C failed to detect any carriers, suggesting that this was a private mutation of this family.

Conclusion: The high incidence of 11-OHD in MJ, therefore, is only partially explained by the presence of R448H as a founder mutation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society